AEMD

Aethlon Medical (AEMD)

Aethlon Medical Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AEMD

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/11/16	06 : 40	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:AEMD	Aethlon Medical Inc
2024/11/14	07 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AEMD	Aethlon Medical Inc
2024/11/14	06 : 15	PR Newswire (US)	Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update	NASDAQ:AEMD	Aethlon Medical Inc
2024/11/12	23 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AEMD	Aethlon Medical Inc
2024/11/11	22 : 01	PR Newswire (US)	Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia	NASDAQ:AEMD	Aethlon Medical Inc
2024/11/06	22 : 01	PR Newswire (US)	Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024	NASDAQ:AEMD	Aethlon Medical Inc
2024/10/08	21 : 01	PR Newswire (US)	Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit	NASDAQ:AEMD	Aethlon Medical Inc
2024/10/04	05 : 44	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AEMD	Aethlon Medical Inc
2024/10/03	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AEMD	Aethlon Medical Inc
2024/10/02	06 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AEMD	Aethlon Medical Inc
2024/10/02	06 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AEMD	Aethlon Medical Inc
2024/10/02	06 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AEMD	Aethlon Medical Inc
2024/09/19	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AEMD	Aethlon Medical Inc
2024/09/19	21 : 01	PR Newswire (US)	Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India	NASDAQ:AEMD	Aethlon Medical Inc
2024/09/16	21 : 01	PR Newswire (US)	Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial	NASDAQ:AEMD	Aethlon Medical Inc
2024/09/13	21 : 35	GlobeNewswire Inc.	Aethlon Medical to Present at the Life Sciences Investor Forum September 19th	NASDAQ:AEMD	Aethlon Medical Inc
2024/08/27	21 : 01	PR Newswire (US)	Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys	NASDAQ:AEMD	Aethlon Medical Inc
2024/08/16	05 : 34	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:AEMD	Aethlon Medical Inc
2024/08/16	05 : 32	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:AEMD	Aethlon Medical Inc
2024/08/16	05 : 30	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:AEMD	Aethlon Medical Inc
2024/08/16	05 : 15	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:AEMD	Aethlon Medical Inc
2024/08/15	06 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AEMD	Aethlon Medical Inc
2024/08/15	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AEMD	Aethlon Medical Inc
2024/08/15	05 : 15	PR Newswire (US)	Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update	NASDAQ:AEMD	Aethlon Medical Inc
2024/08/12	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AEMD	Aethlon Medical Inc
2024/08/12	21 : 01	PR Newswire (US)	Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial	NASDAQ:AEMD	Aethlon Medical Inc
2024/08/06	22 : 12	PR Newswire (US)	Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024	NASDAQ:AEMD	Aethlon Medical Inc
2024/06/28	05 : 15	PR Newswire (US)	Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update	NASDAQ:AEMD	Aethlon Medical Inc
2024/06/21	21 : 01	PR Newswire (US)	Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024	NASDAQ:AEMD	Aethlon Medical Inc
2024/06/18	21 : 01	PR Newswire (US)	Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial	NASDAQ:AEMD	Aethlon Medical Inc